Science Explorer Back to mapMap
Discussion
Researcher · ImmunoGen (United States) · United States

Victor S. Goldmacher

Victor S. Goldmacher publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Toxin Mechanisms and Immunotoxins.

ORCID 0000-0001-6130-4436 OpenAlex
World rank
#153,758
of 7,710,434 ranked researchers
Rank in United States
#57,912
of 1,627,098
Works
156
Citations
8.6k
Citations per work
55.1
h-index
45
i10-index 77Top 5.1% in Molecular Biology
Victor S. Goldmacher

What does Victor S. Goldmacher research?

Victor S. Goldmacher's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (12%).

Health Sciences: 56 works · 35.7% of their workMedicine: 56 works · 35.7% of their workRadiology, Nuclear Medicine and Imaging: 26 works · 16.5% of their workOncology: 22 works · 13.9% of their workEpidemiology: 8 works · 5.3% of their workLife Sciences: 55 works · 35.4% of their workBiochemistry, Genetics and Molecular Biology: 36 works · 23.0% of their workMolecular Biology: 28 works · 18.0% of their workBiotechnology: 8 works · 5.0% of their workImmunology and Microbiology: 19 works · 12.4% of their workImmunology: 19 works · 12.4% of their workEverything else: 45 works · 28.9% of their workTHEIR WORKVictor S.Goldmacher156works
Life Sciences35%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5635.7%
    1. Biochemistry, Genetics and Molecular Biology3623.0%
    2. Immunology and Microbiology1912.4%
  3. Everything else4528.9%
  1. 1Molecular Biology18% of their works
  2. 2Radiology, Nuclear Medicine and Imaging16% of their works
  3. 3Oncology14% of their works
  4. 4Immunology12% of their works
  5. 5Epidemiology5% of their works
  6. 6Biotechnology5% of their works

Research topics

Which keywords describe Victor S. Goldmacher's research?

The keywords of their largest research topics: Glycosylation, Fc Receptors, Therapeutic Antibodies, Targeted Therapy, Breast Cancer, HER2, Immunotoxin and Ricin Poisoning.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Glycosylation592 topics
  2. Fc Receptors451 topic
  3. Therapeutic Antibodies451 topic
  4. Targeted Therapy402 topics
  5. Breast Cancer321 topic
  6. HER2321 topic
  7. Immunotoxin291 topic
  8. Ricin Poisoning291 topic
  9. Plant Molecular Farming161 topic
  10. Recombinant Proteins161 topic
  11. Cancer141 topic
  12. Glycans141 topic
  13. Cytomegalovirus131 topic
  14. Infection131 topic
  15. Neosporosis111 topic
  16. PET Imaging111 topic
  17. Radiopharmaceuticals111 topic
  18. Toxoplasma gondii111 topic

Where does Victor S. Goldmacher work?

Victor S. Goldmacher's main affiliation in the publication record is ImmunoGen (United States), United States.

How many publications and citations does Victor S. Goldmacher have?

OpenAlex counts 156 works and 8,591 citations for Victor S. Goldmacher, an h-index of 45, ranking #153,758 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Victor S. Goldmacher. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.